Indeed, deletion of ERβ led to reduction of tumor growth [104]; and Tamoxifen, a selective estrogen receptor modulator (SERM) that inhibits ER activity, provides chemoprevention against urothelial carcinogenesis in mice [105]. This evidence concerns the gene ESR2 and neoplasm.